Wahed Invest’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $284K | Buy |
5,165
+280
| +6% | +$15.4K | 0.04% | 213 |
|
|
2025
Q1 | $345K | Buy |
4,885
+4
| +0.1% | +$283 | 0.06% | 195 |
|
|
2024
Q4 | $321K | Buy |
4,881
+297
| +6% | +$19.5K | 0.05% | 197 |
|
|
2024
Q3 | $322K | Buy |
4,584
+470
| +11% | +$33K | 0.06% | 194 |
|
|
2024
Q2 | $339K | Buy |
4,114
+460
| +13% | +$37.9K | 0.07% | 168 |
|
|
2024
Q1 | $319K | Buy |
3,654
+463
| +15% | +$40.4K | 0.07% | 168 |
|
|
2023
Q4 | $308K | Buy |
3,191
+290
| +10% | +$28K | 0.09% | 160 |
|
|
2023
Q3 | $257K | Buy |
2,901
+207
| +8% | +$18.3K | 0.08% | 164 |
|
|
2023
Q2 | $234K | Buy |
2,694
+279
| +12% | +$24.2K | 0.08% | 168 |
|
|
2023
Q1 | $235K | Buy |
2,415
+62
| +3% | +$6.03K | 0.1% | 153 |
|
|
2022
Q4 | $244K | Buy |
2,353
+234
| +11% | +$24.2K | 0.13% | 142 |
|
|
2022
Q3 | $180K | Buy |
2,119
+146
| +7% | +$12.4K | 0.11% | 150 |
|
|
2022
Q2 | $164K | Buy |
+1,973
| New | +$164K | 0.1% | 155 |
|
|
2022
Q1 | – | Sell |
-2,183
| Closed | -$193K | – | 176 |
|
|
2021
Q4 | $193K | Buy |
+2,183
| New | +$193K | 0.11% | 164 |
|